Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mucositis × brilacidin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Stomatitis 1 Mucositis 1 Head and Neck Neoplasms 1

Interventions

Radiotherapy 6 Cisplatin 5 Radiation 4 Injections 4 Fibroblast Growth Factor 7 4 Propolis 3 Morphine 3 Low-Level Light Therapy 3 Drug Therapy 3 angiotensin I (1-7) 2 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Water 2 Radiotherapy, Intensity-Modulated 2 RRx-001 2 Probiotics 2 Pentoxifylline 2 Mouthwashes 2 Methotrexate 2 Melphalan 2 Lidocaine 2 Leucovorin 2 Interleukin 1 Receptor Antagonist Protein 2 Honey 2 Gabapentin 2 Fluorouracil 2 Diphenhydramine 2 Cryotherapy 2 Amifostine 2 tempol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed

61 enrolled 12 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡